How Smarteeva Identified the Top 5 Trends Reshaping Post-Market Surveillance

Trend 1: Partner and Customer Self-Service Portals

Consumer-grade medical devices now let patients monitor and manage their own health. As these devices put more capability in the user’s hands, the demand for embedded complaint submission has followed. Manufacturers are investing in self-service portals that let patients and distributors report issues directly, without phone calls or email chains.

Smarteeva’s Customer Portal does exactly this. Guided decision trees collect structured complaint data at the source. The data flows directly into the complaint management workflow. No manual re-entry. No incomplete records.

Trend 2: Increased Data Collection and Reporting

Reporting obligations are expanding in both the US and Europe. FDA has retired some summary reporting exemptions, pushing more adverse events into the public MAUDE system. The EU MDR MIR form expanded from 4 pages to 12, requiring more granular data mapping, collection, and submission.

For PMS teams, this means higher volume and more complex reports. Smarteeva automates data aggregation across complaint records, investigations, and external sources. PSUR generation takes 8 minutes. MDR submission takes 3 minutes. The increased reporting burden becomes a workflow problem, not a staffing crisis.

Trend 3: EU Data Protection and Data Residency

GDPR and EU MDR together have forced medical device companies to rethink where patient data lives. The trend is clear: EU personal data stays within EU borders. This affects application hosting, support staffing, and vendor selection.

Smarteeva runs on Salesforce, which offers EU-hosted instances with full data residency controls. Companies do not need to choose between compliance and functionality.

Trend 4: Generative AI in Complaint Management

Generative AI is the most discussed trend in MedTech operations. Every company wants to invest. Few have shipped production systems that pass validation. The gap between interest and implementation is wide.

Smarteeva has shipped. The platform’s AI engine achieves 96% first-pass extraction accuracy on complaint intake. Orchestra, the no-code AI agent builder, lets quality teams build and deploy agents in 10 minutes. These are not pilot projects. They run in production across global MedTech companies.

96% first-pass extraction accuracy on incoming complaint data

10 min from blank canvas to running an AI agent with Orchestra

Trend 5: The Growing Importance of MAUDE Data

Keywords: MAUDE database medical devices, FDA MAUDE competitive intelligence

The FDA’s MAUDE database is becoming a strategic asset. Manufacturers use it for competitive benchmarking, signal detection, and regulatory preparation. The data volume is now large enough to surface meaningful patterns across device categories, companies, and time periods.

Smarteeva’s MDREngine aggregates 2.6M+ global safety records, including the full MAUDE dataset. Teams can cross-reference their internal complaint data against industry benchmarks, monitor competitor devices, and validate emerging signals against public FDA data.

2.6M+ global safety records aggregated in MDREngine

‍

Closing

These five trends are not predictions. They are investments happening now across the medical device industry. Smarteeva’s platform was built to address each one: self-service complaint intake, automated regulatory reporting, EU data residency, production AI, and global safety intelligence.

‍